Home
Contact Us
Log In
About Us
History
Facts & Figures
Network
Management Team
Investment Committee
Portfolio
Portfolio At A Glance
Neupogen / Neulasta
Remicade
Humira
Rituxan
Atripla / Truvada / Emtriva
Thalomid
Lyrica
Prezista
Letairis / Volibris
RotaTeq
Cubicin
Savella
Myozyme / Lumizyme
Lexiscan
Januvia / Janumet
Onglyza / Kombiglyze
Galvus / Eucreas
Nesina
Tradjenta
TOBI
Viviant
Cimzia
Mircera
Vosaroxin
Tecfidera
Conbriza/Aprela
Approach
Investment Criteria
Investment Process
Case Studies
Resource Center
Royalties Explained
Royalty Valuation
Royalty Market Overview
Benefits of Monetization
News & Events
Press Releases
Proposed Offer for Elan
Calendar of Events
15th Anniversary
Contact Us
Financing
Business Affairs/Legal
Investor Relations
Business Development
Address & Direction
This option will not work correctly. Unfortunately, your browser does not support inline frames.
